Cellect: Unveiling the Potential Impact on Patent Term Adjustment
We recognize also that a much large percentage of patents have a terminal disclaimer on file — having already given up any statutory right to PTA.
Archive for July, 2024
-
In: PATENT NEWS
-
In: COPYRIGHT NEWS
NBC Settles Copyright Suit Over ‘Four Seasons’ Documentary Clips – Bloomberg Law
NBC Settles Copyright Suit Over ‘Four Seasons’ Documentary Clips Bloomberg Law
-
In: PATENT NEWS
Prof. Kristin Hickman Quoted in Bloomberg Tax About Corner Post Ruling and its Ramifications
S.J.D. · Curriculum & Requirements · S.J.D. Candidates · M.S. in Patent Law · How to Apply · Curriculum & Requirements · Where Students Go …
-
In: PATENT NEWS
Cellect: Unveiling the Potential Impact on Patent Term Adjustment – Patently-O
Cellect: Unveiling the Potential Impact on Patent Term Adjustment Patently-O
-
In: PATENT NEWS
Charter Rebuffed by Appeals Court in Bid to Escape Patent Suit – Bloomberg Law
Charter Rebuffed by Appeals Court in Bid to Escape Patent Suit Bloomberg Law
-
In: PATENT NEWS
Recon: Eli Lilly to buy Morphic for $3.2 billion; White House appeals patent decision on HIV preventives – Regulatory Focus
Recon: Eli Lilly to buy Morphic for $3.2 billion; White House appeals patent decision on HIV preventives Regulatory Focus
-
In: PATENT NEWS
Federal Circuit Wades Into Article III Standing in Patent Cases Once Again – Lexology
In certain instances, a secured creditor can obtain rights that become actionable only upon default, which may include the ability to license or …
-
In: PATENT NEWS
IN BRIEF: Shortwave Life Sciences says patent claim gets endorsement – Morningstar
Copyright 2024 Alliance News Ltd. All Rights reserved. Email Form Facebook Twitter LinkedIn · RSS.
-
In: PATENT NEWS
Federal Circuit Upends Obviousness Test for Design Patents, Leaving Uncertainty and … – JD Supra
… patent decisions. Following this decision, a new framework will be … Similarly, the American Intellectual Property Law Association (AIPLA) …
-
In: PATENT NEWS
Christopher Sweeney Named Executive Director, Intellectual Property at Acuitas …
VANCOUVER, BC – Acuitas Therapeutics, Inc.’s Chief Legal Officer & Vice President of Business Development, Miranda Lam, KC, recently announced …